Clomipramine
ADVERTISEMENT
- Molecular formula
- C19H23N
- CAS Number
- 303-49-1
- IUPAC Name
- N,N-dimethyl-2-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyl)ethanamine
- Molecular Weight
- 314.88g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.2163g/cm3
- Synonyms
- 23509-37-7
Identification
Interesting facts
Interesting Facts about N,N-Dimethyl-2-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyl)ethanamine
N,N-dimethyl-2-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyl)ethanamine, a fascinating compound, showcases the intricate structures and diverse applications of organic chemistry. Here are some interesting insights into this compound:
- Complex Structure: The tricyclic framework in this compound encapsulates a unique arrangement of carbon atoms, highlighting the complexity and beauty of molecular architecture.
- Biological Activity: Compounds similar to this can exhibit intriguing biological properties, making them potential candidates for pharmacological studies, especially in the fields of neurobiology and cancer research.
- Synthetic Pathways: The synthesis of this compound involves multiple steps, providing a rich landscape for organic chemistry enthusiasts to explore diverse reactions, such as cyclizations and functional group modifications.
- Potential Applications: The structural motifs found within this compound suggest potential uses in drug design and catalysis, paving the way for innovative solutions in medicinal chemistry and material science.
- Research Interest: Because of its complex structure, this compound is often a subject of interest in academic circles, encouraging research into its synthesis, properties, and potential applications.
As noted by chemists, "The beauty of organic chemistry lies in its ability to weave together simple elements to create intricate and novel compounds." The world of N,N-dimethyl-2-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyl)ethanamine, with its myriad possibilities, is a testament to this statement.